...
首页> 外文期刊>Indian Journal of Ophthalmology >Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population
【24h】

Surgical outcomes of microincision vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in Indian population

机译:印度人群早产儿视网膜病变继发视网膜脱离的眼显微切割玻璃体切除术的手术效果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: To analyze and report outcomes of microincision vitrectomy surgery (MIVS) for Stage 4 and 5 retinopathy of prematurity (ROP). Methods: Medical records of 202 eyes of 129 premature children undergoing MIVS for Stage 4/Stage 5 ROP between January 2012 and April 2015 were evaluated. The primary outcome measure was the proportion of eyes with anatomical success (defined as attached retina at the posterior pole at last follow-up). Complications associated with MIVS were noted and analysis of risk factors associated with poor anatomical outcome was also done using logistic regression. Results: Mean age of presentation of babies with Stage 4 ROP (2.9 ± 1.75 months) was lower than those with stage 5 disease (5.62 ± 2.55 months) (P 0.005). One hundred seventeen eyes (56% or 58%) had Stage 5, 38 (19%) had Stage 4a, and 47 (23%) Stage 4b. Ninety-four eyes (47%) had received prior treatment (laser and/or anti-vascular endothelial growth factors [VEGF]). Lens-sparing vitrectomy (LSV) was performed in 58 (29%) eyes while lensectomy with vitrectomy (LV) was performed in 144 (71%) eyes. At a mean follow-up of 32.5 weeks, 102 (50.5%) eyes achieved anatomical success, including 74% eyes in Stage 4a and 4b and 33% in Stage 5. Complications included intraoperative break formation (19%), postoperative vitreous hemorrhage (28%), raised intraocular pressure (12.7%), and cataract progression (2.4%). Factors significantly associated with favorable anatomical outcome were Stage 4 disease (vs. Stage 5) (odds ratio [OR] 5.8; confidence interval [CI] =2.6–13.8, P 0.005), prior treatment (laser ± anti-VEGF) (OR 2.5; CI 1.4–4.7, P 0.005) surgery with 25G MIVS (vs. 23G) (OR: 1.7; CI = 0.98–3.00, P = 0.05) and LSV (vs. LV) (OR 7; CI = 3.4–14.6, P 0.005). Retinal break was significantly associated with poor anatomical outcome (OR 0.21; CI = 0.09–0.5, P 0.005). Conclusion: MIVS along with wide angle viewing systems allow surgeons to effectively manage ROP surgeries while at the same time reducing complication rate in these eyes which have complex pathoanatomy and otherwise grim prognosis.
机译:目的:分析和报告微切口玻璃体切除术手术(MIVS)的4期和5期早产儿视网膜病变(ROP)的结果。方法:对2012年1月至2015年4月期间进行MIVS 4期/ 5期ROP的129例早产儿202眼的病历进行了评估。主要结果指标是解剖学上成功的眼睛比例(定义为最后一次随访时后极附着的视网膜)。记录了与MIVS相关的并发症,并使用logistic回归分析了与不良解剖结果相关的危险因素。结果:患有4期ROP的婴儿的平均出现年龄(2.9±1.75个月)低于患有5期疾病的婴儿的平均呈现年龄(5.62±2.55个月)(P <0.005)。 117眼(56%或58%)处于第5阶段,38眼(19%)具有第4a阶段,47眼(23%)处于第4b阶段。 94眼(47%)已接受过先前治疗(激光和/或抗血管内皮生长因子[VEGF])。 58眼(​​29%)进行了保留晶状体玻璃体切除术(LSV),而144眼(71%)进行了晶状体玻璃体切除术(LV)。在平均32.5周的随访中,有102例(50.5%)的眼获得了解剖学上的成功,其中74%的眼睛处于4a和4b期,而33%的患者处于5期。并发症包括术中破裂形成(19%),术后玻璃体出血( 28%),眼压升高(12.7%)和白内障进展(2.4%)。与良好的解剖学结局显着相关的因素是第4阶段疾病(vs.第5阶段)(优势比[OR] 5.8;置信区间[CI] = 2.6-13.8,P <0.005),先前治疗(激光±抗VEGF)( OR 2.5; CI为1.4-4.7,P <0.005)25G MIVS(vs. 23G)(OR:1.7; CI = 0.98-3.00,P = 0.05)和LSV(vs. LV)(OR 7; CI = 3.4) –14.6,P <0.005)。视网膜破裂与不良的解剖结果显着相关(OR 0.21; CI = 0.09–0.5,P <0.005)。结论:MIVS和广角观察系统使外科医生能够有效地处理ROP手术,同时降低这些具有复杂病理解剖学和其他预后不良的眼睛的并发症发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号